-+ 0.00%
-+ 0.00%
-+ 0.00%

BioAtla Q4 EPS $(0.16) Beats $(0.30) Estimate, Sales $2.000M Beat $700.000K Estimate

Benzinga·03/31/2026 21:03:30
Listen to the news
BioAtla (NASDAQ:BCAB) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.30) by 47.19 percent. This is a 46.67 percent increase over losses of $(0.30) per share from the same period last year. The company reported quarterly sales of $2.000 million which beat the analyst consensus estimate of $700.000 thousand by 185.71 percent.